I am a US correspondent and data journalist for The Economist.
I write about politics & policy in the United States.
I attended the University of Michigan for both undergraduate and graduate school.
A surge in diagnoses has created a booming industry
The Trump administration seems to want less clean energy and more preventable diseases
The economics of American college sports have been upended
The already fraught oversight of rare-disease treatments is becoming politicised
Cuts to funding risk hobbling Boston's science establishment
They are less enthusiastic about Donald Trump than their counterparts elsewhere